HEADER OXIDOREDUCTASE 03-JUN-05 1ZW1 TITLE SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL ANALYSIS TITLE 2 OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REDUCTASE. PART TITLE 3 1:4'-SUBSTITUTED TRICLOSAN DERIVATIVES COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.3.1.9; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: PFENR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+-RIL CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.FREUNDLICH,J.W.ANDERSON,D.SARANTAKIS,H.M.SHIEH,M.YU,E.LUCUMI, AUTHOR 2 M.KUO,G.A.SCHIEHSER,D.P.JACOBUS,W.R.JACOBS JR.,D.A.FIDOCK, AUTHOR 3 J.C.SACCHETTINI REVDAT 4 23-AUG-23 1ZW1 1 REMARK REVDAT 3 13-JUL-11 1ZW1 1 VERSN REVDAT 2 24-FEB-09 1ZW1 1 VERSN REVDAT 1 06-JUN-06 1ZW1 0 JRNL AUTH J.S.FREUNDLICH,J.W.ANDERSON,D.SARANTAKIS,H.M.SHIEH,M.YU, JRNL AUTH 2 J.C.VALDERRAMOS,E.LUCUMI,M.KUO,W.R.JACOBS,D.A.FIDOCK, JRNL AUTH 3 G.A.SCHIEHSER,D.P.JACOBUS,J.C.SACCHETTINI JRNL TITL SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL JRNL TITL 2 ANALYSIS OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACYL JRNL TITL 3 CARRIER PROTEIN REDUCTASE. PART 1: 4'-SUBSTITUTED TRICLOSAN JRNL TITL 4 DERIVATIVES. JRNL REF BIOORG.MED.CHEM.LETT. V. 15 5247 2005 JRNL REFN ISSN 0960-894X JRNL PMID 16198563 JRNL DOI 10.1016/J.BMCL.2005.08.044 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 15320 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1524 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4574 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.13900 REMARK 3 B22 (A**2) : 0.13900 REMARK 3 B33 (A**2) : -0.27800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 15.67 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NAD.PAR REMARK 3 PARAMETER FILE 3 : TNA.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ZW1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUN-05. REMARK 100 THE DEPOSITION ID IS D_1000033188. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDIP REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16254 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.899 REMARK 200 RESOLUTION RANGE LOW (A) : 29.722 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1NHD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.60, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.44850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.63300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.63300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.17275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.63300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.63300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.72425 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.63300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.63300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.17275 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.63300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.63300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.72425 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.44850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 24240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -171.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 131.26600 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 131.26600 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.44850 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 326 REMARK 465 ASN A 327 REMARK 465 ASN A 328 REMARK 465 THR A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 ASN A 332 REMARK 465 ASN A 333 REMARK 465 THR A 334 REMARK 465 ASN A 335 REMARK 465 GLN A 336 REMARK 465 ASN A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 339 REMARK 465 ARG A 340 REMARK 465 ASN A 341 REMARK 465 SER A 342 REMARK 465 HIS A 343 REMARK 465 ASP A 344 REMARK 465 VAL A 345 REMARK 465 HIS A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 MET A 349 REMARK 465 ASN A 350 REMARK 465 ASN A 351 REMARK 465 SER A 352 REMARK 465 GLY A 353 REMARK 465 GLU A 354 REMARK 465 LYS A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 LYS A 358 REMARK 465 LYS A 359 REMARK 465 ASN A 360 REMARK 465 SER A 361 REMARK 465 ALA A 362 REMARK 465 SER A 363 REMARK 465 GLN A 364 REMARK 465 ASN A 365 REMARK 465 ILE A 426 REMARK 465 TYR A 427 REMARK 465 ARG A 428 REMARK 465 ASN A 429 REMARK 465 GLU A 430 REMARK 465 ASN A 431 REMARK 465 GLU A 432 REMARK 465 LEU B 326 REMARK 465 ASN B 327 REMARK 465 ASN B 328 REMARK 465 THR B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 ASN B 332 REMARK 465 ASN B 333 REMARK 465 THR B 334 REMARK 465 ASN B 335 REMARK 465 GLN B 336 REMARK 465 ASN B 337 REMARK 465 LYS B 338 REMARK 465 ASN B 339 REMARK 465 ARG B 340 REMARK 465 ASN B 341 REMARK 465 SER B 342 REMARK 465 HIS B 343 REMARK 465 ASP B 344 REMARK 465 VAL B 345 REMARK 465 HIS B 346 REMARK 465 ASN B 347 REMARK 465 ILE B 348 REMARK 465 MET B 349 REMARK 465 ASN B 350 REMARK 465 ASN B 351 REMARK 465 SER B 352 REMARK 465 GLY B 353 REMARK 465 GLU B 354 REMARK 465 LYS B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 LYS B 358 REMARK 465 LYS B 359 REMARK 465 ASN B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 SER B 363 REMARK 465 GLN B 364 REMARK 465 ASN B 365 REMARK 465 ILE B 426 REMARK 465 TYR B 427 REMARK 465 ARG B 428 REMARK 465 ASN B 429 REMARK 465 GLU B 430 REMARK 465 ASN B 431 REMARK 465 GLU B 432 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 107 -147.45 -137.76 REMARK 500 ASP A 154 -88.73 -34.67 REMARK 500 LYS A 155 74.60 -40.41 REMARK 500 ASP A 156 61.28 12.21 REMARK 500 GLU A 180 -70.73 -56.10 REMARK 500 ASN A 184 117.77 -28.49 REMARK 500 LYS A 185 -60.15 -24.84 REMARK 500 SER A 215 58.60 -114.12 REMARK 500 ASN A 218 123.77 -176.18 REMARK 500 SER A 242 -61.53 -120.45 REMARK 500 SER A 260 -177.80 -68.95 REMARK 500 HIS A 268 -6.52 -52.33 REMARK 500 PRO A 275 125.40 -36.76 REMARK 500 TYR A 277 66.89 -104.18 REMARK 500 ASN A 324 113.65 68.49 REMARK 500 THR A 367 130.01 74.34 REMARK 500 GLU A 402 5.92 -65.91 REMARK 500 ARG A 404 -27.27 -36.68 REMARK 500 PHE A 421 -84.07 -125.92 REMARK 500 ASP B 107 154.54 142.95 REMARK 500 ASN B 123 33.62 70.56 REMARK 500 ASP B 154 -60.86 -18.46 REMARK 500 LYS B 155 42.89 -55.36 REMARK 500 ASP B 156 34.06 38.08 REMARK 500 MET B 159 150.43 -36.27 REMARK 500 ASN B 160 67.09 -117.00 REMARK 500 ASN B 210 39.52 -142.50 REMARK 500 MET B 211 114.43 -167.72 REMARK 500 ALA B 219 100.87 -162.37 REMARK 500 LEU B 226 -67.19 -19.59 REMARK 500 SER B 242 -64.06 -97.12 REMARK 500 SER B 244 -36.25 -38.76 REMARK 500 ALA B 269 -5.66 -56.95 REMARK 500 THR B 367 -171.49 49.53 REMARK 500 ARG B 404 -16.85 -47.63 REMARK 500 ASP B 414 27.98 -160.36 REMARK 500 PHE B 421 -76.16 -110.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 451 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TN5 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TN5 B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NHD RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT BOUND INHIBITOR REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN REMARK 900 RELATED ID: 1NHW RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1NNU RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZSN RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG DBREF 1ZW1 A 97 432 UNP Q9BH77 Q9BH77_PLAFA 97 432 DBREF 1ZW1 B 97 432 UNP Q9BH77 Q9BH77_PLAFA 97 432 SEQRES 1 A 336 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 A 336 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 A 336 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 A 336 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 A 336 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 A 336 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 A 336 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 A 336 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 A 336 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 A 336 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 A 336 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 A 336 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 A 336 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 A 336 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 A 336 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 A 336 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 A 336 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 A 336 ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR TYR SEQRES 19 A 336 GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN SER HIS SEQRES 20 A 336 ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS GLU SEQRES 21 A 336 GLU LYS LYS ASN SER ALA SER GLN ASN TYR THR PHE ILE SEQRES 22 A 336 ASP TYR ALA ILE GLU TYR SER GLU LYS TYR ALA PRO LEU SEQRES 23 A 336 ARG GLN LYS LEU LEU SER THR ASP ILE GLY SER VAL ALA SEQRES 24 A 336 SER PHE LEU LEU SER ARG GLU SER ARG ALA ILE THR GLY SEQRES 25 A 336 GLN THR ILE TYR VAL ASP ASN GLY LEU ASN ILE MET PHE SEQRES 26 A 336 LEU PRO ASP ASP ILE TYR ARG ASN GLU ASN GLU SEQRES 1 B 336 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 B 336 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 B 336 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 B 336 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 B 336 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 B 336 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 B 336 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 B 336 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 B 336 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 B 336 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 B 336 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 B 336 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 B 336 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 B 336 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 B 336 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 B 336 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 B 336 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 B 336 ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR TYR SEQRES 19 B 336 GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN SER HIS SEQRES 20 B 336 ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS GLU SEQRES 21 B 336 GLU LYS LYS ASN SER ALA SER GLN ASN TYR THR PHE ILE SEQRES 22 B 336 ASP TYR ALA ILE GLU TYR SER GLU LYS TYR ALA PRO LEU SEQRES 23 B 336 ARG GLN LYS LEU LEU SER THR ASP ILE GLY SER VAL ALA SEQRES 24 B 336 SER PHE LEU LEU SER ARG GLU SER ARG ALA ILE THR GLY SEQRES 25 B 336 GLN THR ILE TYR VAL ASP ASN GLY LEU ASN ILE MET PHE SEQRES 26 B 336 LEU PRO ASP ASP ILE TYR ARG ASN GLU ASN GLU HET NAD A 450 44 HET TN5 A 500 17 HET NAD B 451 44 HET TN5 B 501 17 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM TN5 2-(4-AMINO-2-CHLOROPHENOXY)-5-CHLOROPHENOL FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 TN5 2(C12 H9 CL2 N O2) HELIX 1 1 GLY A 110 LYS A 121 1 12 HELIX 2 2 TRP A 131 GLY A 145 1 15 HELIX 3 3 ASP A 148 ILE A 152 5 5 HELIX 4 4 ASP A 178 ASN A 184 1 7 HELIX 5 5 ARG A 186 LEU A 190 5 5 HELIX 6 6 THR A 194 TYR A 206 1 13 HELIX 7 7 ASP A 225 THR A 229 5 5 HELIX 8 8 SER A 230 SER A 242 1 13 HELIX 9 9 SER A 242 VAL A 253 1 12 HELIX 10 10 TYR A 267 GLN A 271 5 5 HELIX 11 11 GLY A 280 TYR A 303 1 24 HELIX 12 12 SER A 317 ASN A 324 1 8 HELIX 13 13 THR A 367 ALA A 380 1 14 HELIX 14 14 LEU A 387 LEU A 399 1 13 HELIX 15 15 GLY A 416 MET A 420 5 5 HELIX 16 16 GLY B 110 ARG B 122 1 13 HELIX 17 17 TRP B 131 ASN B 144 1 14 HELIX 18 18 LYS B 146 ASP B 150 5 5 HELIX 19 19 ASP B 178 ASN B 183 1 6 HELIX 20 20 THR B 194 TYR B 206 1 13 HELIX 21 21 ASP B 225 THR B 229 5 5 HELIX 22 22 SER B 230 SER B 242 1 13 HELIX 23 23 SER B 242 VAL B 253 1 12 HELIX 24 24 TYR B 267 GLN B 271 5 5 HELIX 25 25 GLY B 280 ASN B 304 1 25 HELIX 26 26 SER B 317 ILE B 323 1 7 HELIX 27 27 TYR B 366 ALA B 380 1 15 HELIX 28 28 LEU B 387 SER B 400 1 14 HELIX 29 29 ARG B 401 ARG B 404 5 4 HELIX 30 30 GLY B 416 MET B 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N ILE A 130 O LEU A 165 SHEET 3 A 7 ILE A 99 ILE A 105 1 N ILE A 102 O GLY A 129 SHEET 4 A 7 ILE A 209 HIS A 214 1 O MET A 211 N PHE A 101 SHEET 5 A 7 MET A 256 THR A 266 1 O SER A 261 N LEU A 212 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N THR A 266 SHEET 7 A 7 THR A 410 VAL A 413 1 O ILE A 411 N SER A 311 SHEET 1 B 7 ILE B 161 PRO B 166 0 SHEET 2 B 7 LYS B 125 ILE B 130 1 N PHE B 128 O LEU B 165 SHEET 3 B 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 B 7 ILE B 209 HIS B 214 1 O VAL B 213 N PHE B 101 SHEET 5 B 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 B 7 ARG B 306 ALA B 312 1 O ILE B 310 N SER B 264 SHEET 7 B 7 THR B 410 VAL B 413 1 O ILE B 411 N SER B 311 SHEET 1 C 2 ILE B 152 ILE B 153 0 SHEET 2 C 2 LYS B 157 LYS B 158 -1 O LYS B 157 N ILE B 153 SITE 1 AC1 25 GLY A 104 ILE A 105 GLY A 106 GLY A 110 SITE 2 AC1 25 TYR A 111 TRP A 131 PHE A 167 ASP A 168 SITE 3 AC1 25 ALA A 169 SER A 170 SER A 215 LEU A 216 SITE 4 AC1 25 ALA A 217 ASN A 218 LYS A 240 LEU A 265 SITE 5 AC1 25 THR A 266 LYS A 285 ALA A 312 GLY A 313 SITE 6 AC1 25 PRO A 314 LEU A 315 SER A 317 ALA A 319 SITE 7 AC1 25 TN5 A 500 SITE 1 AC2 24 GLY B 104 GLY B 106 GLY B 110 TYR B 111 SITE 2 AC2 24 TRP B 131 PHE B 167 ASP B 168 ALA B 169 SITE 3 AC2 24 SER B 170 SER B 215 LEU B 216 ALA B 217 SITE 4 AC2 24 ASN B 218 LEU B 265 THR B 266 TYR B 267 SITE 5 AC2 24 LYS B 285 ALA B 312 GLY B 313 PRO B 314 SITE 6 AC2 24 LEU B 315 SER B 317 ALA B 319 TN5 B 501 SITE 1 AC3 10 ALA A 217 ASN A 218 ALA A 219 TYR A 267 SITE 2 AC3 10 TYR A 277 ALA A 319 ALA A 320 ILE A 323 SITE 3 AC3 10 PHE A 368 NAD A 450 SITE 1 AC4 9 ALA B 217 ASN B 218 ALA B 219 TYR B 267 SITE 2 AC4 9 TYR B 277 MET B 281 ALA B 319 PHE B 368 SITE 3 AC4 9 NAD B 451 CRYST1 131.266 131.266 82.897 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007618 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012063 0.00000